| Financial Year |
March 31 2023 |
| Monetary Funds |
2,798,131,329.31 |
| Held-for-trading Financial Assets |
755,089,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
330,737,073.28 |
| Advances to Suppliers |
50,150,230.74 |
| Other Receivables |
29,008,449.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
715,655,910.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,511,186.64 |
| Total Current Assets |
5,466,725,069.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
216,611,984.59 |
| Fixed Assetes |
3,233,093,214.52 |
| Under-construction Projects |
541,798,132.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
639,554,050.40 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,677,456.08 |
| Deferred Income Tax Assets |
91,599,834.04 |
| Other Non-Current Assets |
64,498,500.00 |
| Sub-Total of Non-Current Assets |
4,831,441,678.84 |
| Total Assets |
10,298,166,748.70 |
| Short-Term Loans |
800,572,916.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
323,234,016.26 |
| Accounts Payable |
993,621,624.98 |
| Accounts Received In Advance |
9,203,826.35 |
| Employee Compensation Payable |
35,651,563.32 |
| Taxes Payable |
112,837,311.28 |
| Interest Payable |
-- |
| Dividend Payable |
4,009,965.91 |
| Other payables |
357,059,134.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
302,251,710.57 |
| Other Current Liabilities |
100,444,965.31 |
| Sub-Total of Current Liabilities |
3,154,504,675.36 |
| Long-term Loans |
1,500,400,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
9,980,400.00 |
| Deferred Income Tax Liabilities |
699,756.70 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,580,901,056.97 |
| Total Liabilities |
4,735,405,732.33 |
| Paid-In Capital(Or Share Stock) |
782,208,869.00 |
| Capital Surplus |
1,702,623,695.29 |
| Surplus Reserve |
208,618,551.06 |
| LESS:Treasury Stock |
58,083,411.04 |
| Undistributed Profits |
2,588,100,415.48 |
| Minority Stockholder's Interest |
296,260,834.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,266,500,181.85 |
| Owner's Equity（Stockholder's Equity） |
5,562,761,016.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,298,166,748.70 |
